Physician profile
Yanitza Rodriguez
NPI 1356515019
$276.24
in general payments reported to CMS, 2019-2025
9 companies · $19.84 in 2025
The $19.84 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.61 · 2020: $81.73 · 2021: $20.22 · 2023: $30.04 · 2024: $62.80 · 2025: $19.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $54.53 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $46.37 | 2024 | Ingrezza |
| Janssen Pharmaceuticals, INC | $37.62 | 2019-2020 | |
| Abbvie INC. | $37.43 | 2021-2023 | Qulipta |
| Novartis Pharmaceuticals Corporation | $29.47 | 2019 | |
| Pfizer INC. | $21.72 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $19.84 | 2025 | Farxiga |
| Alkermes, INC. | $16.43 | 2024 | Aristada, Lybalvi |
| Mylan Specialty L.P. | $12.83 | 2023 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yanitza Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.